Home › Funds › Portolan Capital Management, LLC › GEHC
Portolan Capital Management, LLC position in GEHC
GE HEALTHCARE TECHNOLOGIES I · Health Care
Portolan Capital Management, LLC reported holding 542,900 shares of GEHC (GE HEALTHCARE TECHNOLOGIES I) in its Q3 2026 13F filing — a position valued at US$35.5M, representing 1.48% of its reported portfolio and ranking #19 among its reported holdings. Portolan Capital Management, LLC has disclosed GEHC holdings in 4 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Portolan Capital Management, LLC's GEHC position evolved
Portolan Capital Management, LLC first disclosed a stake in GEHC in Q3 2024 at 136,625 shares (US$12.8M). The position peaked in Q3 2026 at 542,900 shares, worth US$35.5M. Across 4 filings, Portolan Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 542,900 shares valued at US$35.5M — an increase of 320,507 shares quarter over quarter.. Notable position changes include a 144% increase in Q3 2026 (shares rose 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 136.62K | $12.82M | New |
| Q1 2025 | 47.44K | $3.83M | New |
| Q2 2026 | 222.39K | $14.24M | New |
| Q3 2026 | 542.90K | $35.49M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GEHC and 13F data
GEHC (GE HEALTHCARE TECHNOLOGIES I) is a Health Care company. 25 other funds we track also report a position in GEHC — the largest reported positions include DODGE & COX (US$3.16B), Dodge & Cox (US$2.42B), Harris Associates (Oakmark) (US$981.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GEHC
- DODGE & COX 48.30M sh · $3.16B · Q3 2026
- Dodge & Cox 37.86M sh · $2.42B · Q2 2026
- Harris Associates (Oakmark) 15.33M sh · $981.25M · Q2 2026
- HARRIS ASSOCIATES L P 14.85M sh · $970.50M · Q3 2026
- BARROW HANLEY MEWHINNEY & STRAUSS LLC 13.77M sh · $900.14M · Q3 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 13.34M sh · $872.20M · Q3 2026
- TRIAN FUND MANAGEMENT, L.P. 3.09M sh · $201.69M · Q3 2026
More on Portolan Capital Management, LLC
FAQ
How long has Portolan Capital Management, LLC held GEHC?
Portolan Capital Management, LLC has disclosed GEHC holdings in 4 of the last 9 reported quarters, going back to Q3 2024.
What is Portolan Capital Management, LLC's current position in GEHC?
As of Q3 2026, Portolan Capital Management, LLC holds 542.90K shares of GEHC (GE HEALTHCARE TECHNOLOGIES I), valued at $35.49M, representing 1.48% of its reported portfolio and ranking #19.
Has Portolan Capital Management, LLC been buying or selling GEHC?
In the latest 13F filing (Q3 2026), Portolan Capital Management, LLC increased its position in GEHC. The position peaked in Q3 2026 at 542.90K shares.
Which other funds hold GEHC?
Other major institutional holders of GEHC include DODGE & COX, Dodge & Cox, Harris Associates (Oakmark), among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.